Fig. 01 -

Title Slide

Fig. 02 -

Conflict of Interest

Fig. 03 -

High-Yield Messages

Fig. 04 -

ILD Diagnosis Matters

Fig. 05 -

New Diagnostic Category

Fig. 06 -

Classification Criteria

Fig. 07 -

Prognosis

Fig. 08 -

IPAF

Fig. 09 -

Pattern

Fig. 10 -

UIP Diagnosis

Fig. 11 -

Treatment Options

Fig. 12 -

Long-term Treatment

Fig. 13 -

Corticosteroid Exposure

Fig. 14 -

Steroid Sparing Therapies

Fig. 15 -

Mycophenolate mofetil

Fig. 16 -

Evidence

Fig. 17 -

Mixed Effects Model

Fig. 18 -

Azathioprine Therapy

Fig. 19 -

MMF Initiation Graphs

Fig. 20 -

Medication Chart

Fig. 21 -

Clinical Trials

Fig. 22 -

ILD is a Minefield

Fig. 23 -

Multidisciplinary Conference

Fig. 24 -

Cardiovascular Disease

Fig. 25 -

Lung Cancer Risk

Fig. 26 -

Acute Exacerbations

Fig. 27 -

Fatal Events

Fig. 28 -

Biomarkers

Fig. 29 -

Rheumatoid Arthritis

Fig. 30 -

Research Directions

Fig. 31 -

Research at Temple

Fig. 32 -

Think About Transplant

Fig. 33 -

Lung Allocation Score

Fig. 34 -

Mortality Rate Increases

Fig. 35 -

High Allocation Score

Fig. 36 -

Timing

Fig. 37 -

Thank You